Solid-phase synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors
Sutton, J.C., Bolton, S.A., Davis, M.E., Hartl, K.S., Jacobson, B., Mathur, A., Ogletree, M.L., Slusarchyk, W.A., Zahler, R., Seiler, S.M., Bisacchi, G.S.(2004) Bioorg Med Chem Lett 14: 2233-2239
- PubMed: 15081015 
- DOI: https://doi.org/10.1016/j.bmcl.2004.02.012
- Primary Citation of Related Structures:  
1RXP - PubMed Abstract: 
A series of nonguanidine N1-activated C4-carboxy azetidinone tryptase inhibitors was prepared by solid-phase methodology to quickly assess the SAR associated with distal functionality on the N1-activating group. From these studies, potent inhibitors with improved specificity were discovered.
Organizational Affiliation: 
The Bristol-Myers Squibb Pharmaceutical Research Institute, PO Box 4000, Princeton, NJ 08543-4000, USA. james.sutton@bms.com